Wilmington, DE, United States of America

Ling Ngo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Siemens Healthcare Diagnostics Gmbh. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ling Ngo - Innovator in Immunoassay Technology

Introduction

Ling Ngo is an accomplished inventor based in Wilmington, DE (US). She has made significant contributions to the field of immunoassays, particularly through her innovative patent that enhances the effectiveness of diagnostic testing.

Latest Patents

Ling Ngo holds a patent for "Labels comprising dibromopyridazinediones for immunoassays and methods of production and use thereof." This patent discloses labels that include dibromopyridazinedione attached to signal molecules. The methods of producing and using these labels are also detailed in her patent. Additionally, the patent covers conjugates of the label attached to an analyte-specific binder, along with methods for their production and use. Kits containing the labels and/or conjugates, as well as microfluidics devices incorporating these innovations, are also disclosed.

Career Highlights

Ling Ngo is currently employed at Siemens Healthcare Diagnostics GmbH, where she continues to advance her research and development efforts in the healthcare diagnostics sector. Her work is pivotal in improving diagnostic accuracy and efficiency.

Collaborations

Ling collaborates with notable colleagues, including Yali Yang and David Wen, who contribute to her projects and research initiatives.

Conclusion

Ling Ngo's innovative work in immunoassay technology exemplifies her commitment to advancing healthcare diagnostics. Her contributions are vital for the development of more effective diagnostic tools.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…